Balance Sheet Asahi Kasei Corporation

Equities

3407

JP3111200006

Diversified Chemicals

Market Closed - Japan Exchange Other stock markets 14:30:00 09/01/2026 HKT			5-day change	1st Jan Change
1,444.00 ^JPY	-0.79%		+3.96%	+3.96%

01-09	Zoll Strengthens Growth Trajectory for Asahi Kasei's Healthcare Sector with U.S. Launch of the Next-Generation Lifevest®? Wcd	CI
01-06	Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025.	CI

d40.Ig0qdTOJkKdHwlfToEsd1trWk2O2IelGxz_Q4RTZqcA.Q0hPLFGwo9IshA2A2mZ5o6uPySGOU4IWoE-htWztwawTRxo2Qt_d7SmtAg

Published financial data: ASAHI KASEI CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2,106B	2,461B	2,726B	2,785B	3,037B
Total Revenues	2,106B	2,461B	2,726B	2,785B	3,037B
Cost of Goods Sold, Total	1,425B	1,692B	1,953B	1,969B	2,079B
Gross Profit	681B	770B	774B	816B	958B
Selling General & Admin Expenses, Total	447B	496B	571B	602B	586B
R&D Expenses	61.53B	71.5B	74.03B	73.35B	80.75B
Depreciation & Amortization - (IS)	-	-	-	-	79.29B
Other Operating Expenses, Total	509B	567B	645B	675B	746B
Operating Income	172B	203B	128B	141B	212B
Interest Expense, Total	-3.21B	-3.64B	-5.91B	-7.45B	-9.1B
Interest And Investment Income	6.2B	5.7B	7.92B	11.19B	13.38B
Net Interest Expenses	2.99B	2.05B	2.01B	3.74B	4.28B
Income (Loss) On Equity Invest.	3.45B	8.88B	923M	-38.11B	-7.19B
Currency Exchange Gains (Loss)	-	-	-2.29B	-	-5.62B
Other Non Operating Income (Expenses)	-2.84B	-1.52B	-7.46B	-16.26B	-9.93B
EBT, Excl. Unusual Items	175B	212B	122B	90.12B	193B
Restructuring Charges	-7.75B	-	-	-	-
Impairment of Goodwill	-406M	-	-	-	-
Gain (Loss) On Sale Of Investments	17.25B	27.73B	29.4B	25.32B	32.38B
Gain (Loss) On Sale Of Assets	-10.28B	-6.61B	-11.79B	-7.52B	-8.17B
Asset Writedown	-1.53B	-6.81B	-189B	-92.83B	-12.18B
Insurance Settlements	2.62B	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-24.4B	-11.24B	-11.6B	13.76B	-10.89B
EBT, Incl. Unusual Items	151B	215B	-61.91B	28.84B	195B
Income Tax Expense	68.81B	51.29B	27.46B	-17.48B	54.2B
Earnings From Continuing Operations	82.1B	164B	-89.37B	46.33B	140B
Net Income to Company	82.1B	164B	-89.37B	46.33B	140B
Minority Interest	-2.33B	-1.95B	-1.94B	-2.52B	-5.41B
Net Income - (IS)	79.77B	162B	-91.31B	43.81B	135B
Net Income to Common Incl Extra Items	79.77B	162B	-91.31B	43.81B	135B
Net Income to Common Excl. Extra Items	79.77B	162B	-91.31B	43.81B	135B
Per Share Items
Net EPS - Basic	57.49	116.68	-65.84	31.6	97.94
Basic EPS - Continuing Operations	57.49	116.68	-65.84	31.6	97.94
Basic Weighted Average Shares Outstanding	1.39B	1.39B	1.39B	1.39B	1.38B
Net EPS - Diluted	57.49	116.68	-65.84	31.6	97.94
Diluted EPS - Continuing Operations	57.49	116.68	-65.84	31.6	97.94
Diluted Weighted Average Shares Outstanding	1.39B	1.39B	1.39B	1.39B	1.38B
Normalized Basic EPS	77.34	94.12	53.37	38.81	83.8
Normalized Diluted EPS	77.34	94.12	53.37	38.81	83.8
Dividend Per Share	34	34	36	36	38
Payout Ratio	57.42	29.15	-53.2	114.05	37.01
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	305B	351B	305B	323B	398B
EBITA	197B	231B	166B	170B	245B
EBIT	172B	203B	128B	141B	212B
Effective Tax Rate - (Ratio)	45.6	23.84	-44.36	-60.62	27.85
Total Current Taxes	73.27B	-	-	-	-
Total Deferred Taxes	-4.46B	-	-	-	-
Normalized Net Income	107B	131B	74.02B	53.8B	116B
Non-Cash Pension Expense	3.57B	1.56B	-1.19B	-2.35B	-1.37B
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	89.74B	98.69B	105B	107B	111B
Maintenance & Repair Expenses, Total	2.03B	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	216B	245B	251B	338B	393B
Short Term Investments	5.54B	-	-	-	-
Total Cash And Short Term Investments	222B	245B	251B	338B	393B
Accounts Receivable, Total	336B	432B	440B	483B	488B
Total Receivables	336B	432B	440B	483B	488B
Inventory	481B	540B	643B	679B	719B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	97.13B	117B	154B	150B	169B
Total Current Assets	1,137B	1,334B	1,488B	1,650B	1,769B
Gross Property Plant And Equipment	2,480B	-	-	-	-
Accumulated Depreciation	-1,763B	-	-	-	-
Net Property Plant And Equipment	717B	805B	872B	853B	921B
Long-term Investments	287B	312B	303B	303B	316B
Goodwill	352B	431B	368B	361B	390B
Other Intangibles, Total	342B	406B	369B	394B	541B
Loans Receivable Long-Term	1.24B	6.23B	8.47B	17.2B	9.56B
Deferred Tax Assets Long-Term	21.12B	54.28B	45.92B	84.56B	69.22B
Other Long-Term Assets, Total	61.65B	-	0	-	-
Total Assets	2,919B	3,349B	3,455B	3,663B	4,015B
Liabilities
Accounts Payable, Total	142B	178B	181B	213B	194B
Accrued Expenses, Total	134B	146B	147B	152B	181B
Short-term Borrowings	229B	352B	320B	261B	290B
Current Portion of Long-Term Debt	-	-	40B	30B	20B
Current Portion of Leases	880M	2.22B	6.77B	7.82B	8.05B
Current Income Taxes Payable	21.27B	58.12B	17.49B	17.83B	18.67B
Other Current Liabilities	176B	187B	200B	233B	253B
Total Current Liabilities	703B	924B	912B	915B	965B
Long-Term Debt	430B	414B	579B	626B	847B
Long-Term Leases	3.92B	8.72B	28.53B	30.73B	29.54B
Pension & Other Post Retirement Benefits	159B	152B	129B	133B	122B
Deferred Tax Liability Non Current	58.67B	52.02B	27.77B	20.18B	55.61B
Other Non Current Liabilities	69.42B	79.81B	81.93B	89.26B	82.69B
Total Liabilities	1,424B	1,630B	1,759B	1,814B	2,101B
Common Stock, Total	103B	103B	103B	103B	103B
Additional Paid In Capital	79.64B	79.89B	79.84B	80.27B	80.32B
Retained Earnings	1,159B	1,282B	1,142B	1,136B	1,191B
Treasury Stock	-5.93B	-6.22B	-7.43B	-7.32B	-8.02B
Comprehensive Income and Other	132B	228B	343B	502B	493B
Total Common Equity	1,467B	1,687B	1,661B	1,813B	1,859B
Minority Interest	27.06B	31.4B	35.09B	35.23B	54.52B
Total Equity	1,495B	1,719B	1,696B	1,849B	1,914B
Total Liabilities And Equity	2,919B	3,349B	3,455B	3,663B	4,015B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.39B	1.39B	1.39B	1.39B	1.36B
ECS Total Common Shares Outstanding	1.39B	1.39B	1.39B	1.39B	1.36B
Book Value / Share	1.06K	1.22K	1.2K	1.31K	1.37K
Tangible Book Value	773B	851B	924B	1,059B	929B
Tangible Book Value Per Share	557.18	613.11	666.73	763.73	683.96
Total Debt	664B	777B	975B	956B	1,195B
Net Debt	442B	533B	724B	617B	802B
Debt Equivalent of Unfunded Proj. Benefit Obligation	159B	151B	103B	91.56B	47.49B
Minority Interest, Total (Incl. Fin. Div)	27.06B	31.4B	35.09B	35.23B	54.52B
Account Code - Inventory Valuation	8	-	-	-	-
Inventories - Raw Materials, Total	112B	142B	170B	190B	194B
Inventories - Work In Process, Total	166B	146B	162B	172B	184B
Inventories - Finished Goods, Total	203B	253B	310B	317B	342B
Land - (BS)	70.58B	-	-	-	-
Buildings, Total	599B	-	-	-	-
Machinery, Total	1,535B	-	-	-	-
Full Time Employees	44.5K	46.75K	48.9K	49.3K	50.35K
Accumulated Allowance for Doubtful Accounts (Supple)	2.22B	2.47B	2.57B	2.88B	3.8B
Order Backlog	528B	533B	503B	520B	567B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	79.77B	215B	-61.91B	28.84B	195B
Depreciation & Amortization - CF	108B	120B	139B	153B	153B
Amortization of Goodwill and Intangible Assets - (CF)	24.9B	28.39B	37.7B	29.6B	32.63B
Depreciation & Amortization, Total	133B	148B	177B	182B	186B
(Gain) Loss From Sale Of Asset	10.28B	13.42B	201B	100B	20.35B
(Gain) Loss on Sale of Investments - (CF)	-17.25B	-26.03B	-29.4B	-25.32B	-30.17B
Asset Writedown & Restructuring Costs	1.94B	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-3.45B	-8.88B	-923M	38.11B	7.19B
Other Operating Activities, Total	3.08B	-57.62B	-105B	-30.8B	-42.4B
Change In Accounts Receivable	5.21B	-45.91B	8.4B	-19.09B	2.82B
Change In Inventories	6.11B	-73.26B	-84.05B	-16.3B	-32.07B
Change In Accounts Payable	1.71B	31.58B	-13.12B	16.21B	-5.62B
Change in Other Net Operating Assets	33B	-13.28B	-1.32B	21.1B	681M
Cash from Operations	254B	183B	90.8B	295B	301B
Capital Expenditure	-133B	-142B	-152B	-148B	-202B
Sale of Property, Plant, and Equipment	656M	1.28B	7.8B	1.18B	723M
Cash Acquisitions	-22.38B	-80.91B	-78.42B	-	-191B
Divestitures	-	-	-	-	1.81B
Sale (Purchase) of Intangible assets	-16.94B	-27.45B	-20.18B	-24.25B	-16.26B
Investment in Marketable and Equity Securities, Total	10.27B	31.59B	34.34B	25.88B	30.3B
Net (Increase) Decrease in Loans Originated / Sold - Investing	4.28B	-3.32B	-4.53B	-5.74B	3.61B
Other Investing Activities, Total	-296M	52M	-614M	8.04B	-8.47B
Cash from Investing	-158B	-221B	-214B	-143B	-381B
Short Term Debt Issued, Total	-	94.63B	11B	-	18.84B
Long-Term Debt Issued, Total	193B	50.9B	260B	126B	306B
Total Debt Issued	193B	146B	271B	126B	325B
Short Term Debt Repaid, Total	-224B	-	-29.78B	-64.67B	-
Long-Term Debt Repaid, Total	-18.16B	-51.09B	-75.46B	-94.5B	-102B
Total Debt Repaid	-242B	-51.09B	-105B	-159B	-102B
Issuance of Common Stock	69M	125M	208M	122M	122M
Repurchase of Common Stock	-10M	-412M	-1.42B	-12M	-30.02B
Common Dividends Paid	-45.8B	-47.19B	-48.58B	-49.96B	-49.96B
Common & Preferred Stock Dividends Paid	-45.8B	-47.19B	-48.58B	-49.96B	-49.96B
Other Financing Activities, Total	-1.79B	-4.64B	-3.85B	-10.81B	2B
Cash from Financing	-95.87B	42.32B	112B	-94.33B	145B
Foreign Exchange Rate Adjustments	9.64B	21.03B	15.74B	29.66B	-8.5B
Miscellaneous Cash Flow Adjustments	1.77B	1.11B	212M	-2.44B	134M
Net Change in Cash	11.46B	26.71B	4.96B	85.6B	56.54B
Supplemental Items
Cash Interest Paid	3.09B	3.65B	5.86B	7.04B	8.55B
Cash Income Tax Paid (Refund)	70.67B	59.14B	111B	34.83B	45.46B
Levered Free Cash Flow	120B	23.65B	-90.19B	88.94B	61.52B
Unlevered Free Cash Flow	122B	25.93B	-86.5B	93.59B	67.21B
Change In Net Working Capital	-31.33B	79.15B	171B	4.61B	33.41B
Net Debt Issued / Repaid	-48.34B	94.43B	165B	-33.67B	222B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.74	4.04	2.36	2.47	3.45
Return on Total Capital	5.05	5.44	3.11	3.21	4.48
Return On Equity %	5.71	10.2	-5.23	2.61	7.46
Return on Common Equity	5.64	10.26	-5.45	2.52	7.35
Margin Analysis
Gross Profit Margin %	32.32	31.27	28.38	29.3	31.55
SG&A Margin	21.24	20.14	20.96	21.61	19.3
EBITDA Margin %	14.49	14.25	11.19	11.6	13.1
EBITA Margin %	9.34	9.39	6.09	6.12	8.05
EBIT Margin %	8.16	8.23	4.71	5.05	6.98
Income From Continuing Operations Margin %	3.9	6.66	-3.28	1.66	4.62
Net Income Margin %	3.79	6.58	-3.35	1.57	4.44
Net Avail. For Common Margin %	3.79	6.58	-3.35	1.57	4.44
Normalized Net Income Margin	5.1	5.31	2.71	1.93	3.8
Levered Free Cash Flow Margin	5.68	0.96	-3.31	3.19	2.03
Unlevered Free Cash Flow Margin	5.78	1.05	-3.17	3.36	2.21
Asset Turnover
Asset Turnover	0.73	0.79	0.8	0.78	0.79
Fixed Assets Turnover	3.07	3.23	3.25	3.23	3.42
Receivables Turnover (Average Receivables)	6.33	6.41	6.25	6.03	6.26
Inventory Turnover (Average Inventory)	2.97	3.31	3.3	2.98	2.97
Short Term Liquidity
Current Ratio	1.62	1.44	1.63	1.8	1.83
Quick Ratio	0.79	0.73	0.76	0.9	0.91
Operating Cash Flow to Current Liabilities	0.36	0.2	0.1	0.32	0.31
Days Sales Outstanding (Average Receivables)	57.7	56.98	58.38	60.66	58.32
Days Outstanding Inventory (Average Inventory)	122.83	110.23	110.54	122.82	122.73
Average Days Payable Outstanding	34.9	33.38	31.85	35.94	35.03
Cash Conversion Cycle (Average Days)	145.63	133.83	137.08	147.54	146.03
Long Term Solvency
Total Debt/Equity	44.41	45.22	57.47	51.69	62.44
Total Debt / Total Capital	30.75	31.14	36.5	34.08	38.44
LT Debt/Equity	29.06	24.58	35.85	35.52	45.81
Long-Term Debt / Total Capital	20.12	16.93	22.76	23.42	28.2
Total Liabilities / Total Assets	48.8	48.68	50.9	49.53	52.33
EBIT / Interest Expense	53.54	55.63	21.73	18.9	23.3
EBITDA / Interest Expense	95.07	96.29	51.63	43.36	43.76
(EBITDA - Capex) / Interest Expense	53.52	57.24	25.91	23.53	21.59
Total Debt / EBITDA	2.18	2.22	3.2	2.96	3
Net Debt / EBITDA	1.45	1.52	2.37	1.91	2.01
Total Debt / (EBITDA - Capex)	3.87	3.73	6.37	5.45	6.09
Net Debt / (EBITDA - Capex)	2.57	2.55	4.73	3.52	4.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.12	16.87	10.77	2.14	9.06
Gross Profit, 1 Yr. Growth %	0.84	13.08	0.52	5.45	17.44
EBITDA, 1 Yr. Growth %	3.22	14.98	-13.05	5.88	23.25
EBITA, 1 Yr. Growth %	-1.42	17.45	-28.13	2.59	43.56
EBIT, 1 Yr. Growth %	-3.08	17.95	-36.66	9.66	50.57
Earnings From Cont. Operations, 1 Yr. Growth %	-22.35	99.56	-154.55	-151.84	203.07
Net Income, 1 Yr. Growth %	-23.25	102.94	-156.41	-147.97	208.17
Normalized Net Income, 1 Yr. Growth %	-4.3	21.69	-43.32	-27.31	114.68
Diluted EPS Before Extra, 1 Yr. Growth %	-23.19	102.95	-156.43	-148	209.91
Accounts Receivable, 1 Yr. Growth %	2.1	28.45	1.85	9.76	0.94
Inventory, 1 Yr. Growth %	0.76	12.21	18.94	5.65	5.97
Net Property, Plant and Equip., 1 Yr. Growth %	9.73	12.26	8.26	-2.11	7.89
Total Assets, 1 Yr. Growth %	3.42	14.74	3.15	6.03	9.62
Tangible Book Value, 1 Yr. Growth %	20.03	10.02	8.65	14.56	-12.26
Common Equity, 1 Yr. Growth %	7.96	14.99	-1.57	9.18	2.54
Cash From Operations, 1 Yr. Growth %	103.82	-27.75	-50.45	225.21	2.1
Capital Expenditures, 1 Yr. Growth %	-3.62	6.68	6.83	-2.81	36.55
Levered Free Cash Flow, 1 Yr. Growth %	-	-80.24	-481.38	-198.61	-30.82
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-78.7	-433.64	-208.2	-28.19
Dividend Per Share, 1 Yr. Growth %	0	0	5.88	0	5.56
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	6.95	13.78	6.37	5.55
Gross Profit, 2 Yr. CAGR %	-	6.79	6.62	2.96	11.28
EBITDA, 2 Yr. CAGR %	-	8.94	-0.01	-4.05	14.24
EBITA, 2 Yr. CAGR %	-	7.6	-8.12	-14.13	21.36
EBIT, 2 Yr. CAGR %	-	6.92	-13.57	-16.66	28.49
Earnings From Cont. Operations, 2 Yr. CAGR %	-	24.48	4.33	-46.82	25.34
Net Income, 2 Yr. CAGR %	-	24.8	6.99	-47.98	21.59
Normalized Net Income, 2 Yr. CAGR %	-	7.91	-16.95	-35.81	24.92
Diluted EPS Before Extra, 2 Yr. CAGR %	-	24.85	7.02	-47.96	21.97
Accounts Receivable, 2 Yr. CAGR %	-	14.52	14.38	5.73	5.26
Inventory, 2 Yr. CAGR %	-	6.33	15.53	12.09	5.81
Net Property, Plant and Equip., 2 Yr. CAGR %	-	10.99	10.24	2.94	2.77
Total Assets, 2 Yr. CAGR %	-	8.93	8.79	4.58	7.81
Tangible Book Value, 2 Yr. CAGR %	-	14.92	9.33	11.56	0.26
Common Equity, 2 Yr. CAGR %	-	11.42	6.39	3.67	5.81
Cash From Operations, 2 Yr. CAGR %	-	21.35	-40.17	26.94	82.21
Capital Expenditures, 2 Yr. CAGR %	-	1.4	6.76	1.9	15.2
Levered Free Cash Flow, 2 Yr. CAGR %	-	-11.35	-13.19	93.92	-17.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-3.05	-15.69	90	-11.85
Dividend Per Share, 2 Yr. CAGR %	-	0	2.9	2.9	2.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	4.28	8.21	9.76	7.26
Gross Profit, 3 Yr. CAGR %	-	3.79	4.66	6.23	7.57
EBITDA, 3 Yr. CAGR %	-	3.82	1.05	1.91	4.3
EBITA, 3 Yr. CAGR %	-	0.31	-5.94	-4.68	1.91
EBIT, 3 Yr. CAGR %	-	-1.12	-10.2	-6.43	1.5
Earnings From Cont. Operations, 3 Yr. CAGR %	-	3.03	-5.45	-17.36	-5.01
Net Income, 3 Yr. CAGR %	-	3.15	-4.22	-18.11	-5.87
Normalized Net Income, 3 Yr. CAGR %	-	-1.15	-12.93	-20.56	-4.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-	3.36	-4.18	-18.08	-5.67
Accounts Receivable, 3 Yr. CAGR %	-	7.56	10.13	12.82	4.11
Inventory, 3 Yr. CAGR %	-	8.13	10.38	12.13	10.01
Net Property, Plant and Equip., 3 Yr. CAGR %	-	9.02	10.07	5.96	4.57
Total Assets, 3 Yr. CAGR %	-	9.15	6.97	7.86	6.23
Tangible Book Value, 3 Yr. CAGR %	-	-0.04	12.79	11.05	2.98
Common Equity, 3 Yr. CAGR %	-	6.9	6.91	7.31	3.29
Cash From Operations, 3 Yr. CAGR %	-	-4.75	-9.98	5.19	18.05
Capital Expenditures, 3 Yr. CAGR %	-	7.44	3.18	3.47	12.34
Levered Free Cash Flow, 3 Yr. CAGR %	-	-35.62	44.18	-9.42	37.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-34.29	46.37	-8.38	37.37
Dividend Per Share, 3 Yr. CAGR %	-	0	1.92	1.92	3.78
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	5.5	5.95	5.11	7.14
Gross Profit, 5 Yr. CAGR %	-	5.58	3.58	3.45	7.26
EBITDA, 5 Yr. CAGR %	-	5.51	-0.44	0.6	6.13
EBITA, 5 Yr. CAGR %	-	5.49	-5.16	-5.74	4.15
EBIT, 5 Yr. CAGR %	-	4.94	-8.35	-7.65	3.64
Earnings From Cont. Operations, 5 Yr. CAGR %	-	7.03	-12.29	-20.92	5.84
Net Income, 5 Yr. CAGR %	-	7.08	-11.71	-21.56	5.37
Normalized Net Income, 5 Yr. CAGR %	-	5.75	-10.78	-16.83	0.59
Diluted EPS Before Extra, 5 Yr. CAGR %	-	7.22	-11.59	-21.45	5.53
Accounts Receivable, 5 Yr. CAGR %	-	7.54	5.36	6.82	8.16
Inventory, 5 Yr. CAGR %	-	9.28	12.3	9.7	8.52
Net Property, Plant and Equip., 5 Yr. CAGR %	-	7.65	9.17	6.55	7.09
Total Assets, 5 Yr. CAGR %	-	8.24	8.32	7.3	7.31
Tangible Book Value, 5 Yr. CAGR %	-	4.32	1.15	4.45	7.6
Common Equity, 5 Yr. CAGR %	-	7.95	5.23	5.59	6.47
Cash From Operations, 5 Yr. CAGR %	-	1.64	-18.33	6.85	19.36
Capital Expenditures, 5 Yr. CAGR %	-	11.38	12.88	5.18	7.83
Levered Free Cash Flow, 5 Yr. CAGR %	-	-18.83	-7.14	0.07	15.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-17.99	-8.31	0.48	19.5
Dividend Per Share, 5 Yr. CAGR %	-	7.21	1.15	1.15	2.25